Overview
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is characterized by excessive water retention leading to hyponatremia due to inappropriate secretion of antidiuretic hormone (ADH), independent of plasma osmolality 1.Diagnosis
Clinical Presentation: Hyponatremia (serum sodium <135 mEq/L) with hypoosmolality (serum osmolality <280 mOsm/kg) 1.
Laboratory Tests: Urine osmolality typically >100 mOsm/kg, urine sodium concentration <30 mEq/L 1.
Water Deprivation Test: Can confirm SIADH by demonstrating inability to increase serum osmolality 1.
ADH Measurement: Elevated plasma ADH levels or elevated urine osmolality/plasma osmolality ratio 1.Management
First-Line Treatment: Fluid restriction to achieve a gradual increase in serum sodium levels 1.
Adjunctive Therapy: Correction of hyponatremia with hypertonic saline (e.g., 3% saline) in severe cases (serum sodium <120 mEq/L) 1.
Drug Considerations: Monitor and consider discontinuation of suspected causative agents like certain PPIs, particularly rabeprazole 1.Special Populations
Elderly: Higher incidence of SIADH associated with PPI use compared to middle-aged patients 1.
Gender Differences: Women appear more frequently affected than men 1.Key Recommendations
Closely monitor elderly patients and women for SIADH when using proton pump inhibitors, especially rabeprazole 1 (Evidence: Moderate).
Implement fluid restriction as the primary management strategy for SIADH 1 (Evidence: Moderate).
Consider hypertonic saline for rapid correction in severe cases of hyponatremia (serum sodium <120 mEq/L) 1 (Evidence: Moderate).References
1 Wang M, Zhang L, Jia M, Wang J, Shen Z, Wang S et al.. Syndrome of inappropriate antidiuretic hormone secretion is associated with different proton pump inhibitor use: a pharmacovigilance study. BMC nephrology 2022. link
2 Pledger DR, Mathew H. Hyponatraemia and clomipramine therapy. The British journal of psychiatry : the journal of mental science 1989. link